2021
Progression of depression and anxiety symptoms in pregnancies conceived by assisted reproductive technology in the United States
Simoni MK, Gilstad-Hayden K, Naqvi SH, Pal L, Yonkers KA. Progression of depression and anxiety symptoms in pregnancies conceived by assisted reproductive technology in the United States. Journal Of Psychosomatic Obstetrics & Gynecology 2021, 43: 214-223. PMID: 34472405, PMCID: PMC10116357, DOI: 10.1080/0167482x.2021.1971193.Peer-Reviewed Original ResearchConceptsAssisted-reproductive technologyEdinburgh Postnatal Depression ScalePlanned pregnanciesPostnatal Depression ScaleGestational time periodsART pregnanciesProspective cohortPregnant womenWeeks postpartumGeneralized Estimating EquationsObstetrical practiceDepression ScaleDepressive symptomsPregnancyBlue studiesSecondary analysisConception groupMental healthAnxiety subscaleAnxiety symptomsWomenGroup changesSymptomsPrevalenceWeeks
2012
Criteria for Premenstrual Dysphoric Disorder: Secondary Analyses of Relevant Data Sets
Hartlage SA, Freels S, Gotman N, Yonkers K. Criteria for Premenstrual Dysphoric Disorder: Secondary Analyses of Relevant Data Sets. JAMA Psychiatry 2012, 69: 300-305. PMID: 22393222, PMCID: PMC3370334, DOI: 10.1001/archgenpsychiatry.2011.1368.Peer-Reviewed Original ResearchConceptsPremenstrual dysphoric disorderDays of mensesDSM-IVPMDD symptomsDysphoric disorderMain outcome measuresOptimal cutoff pointNumber of symptomsSymptomatic periodMenstrual cycleProspective surveyOutcome measuresPerimenstrual symptomsPsychiatric disordersMore symptomsAffective symptomsCutoff pointPhysical symptomsPremenstrual phaseSecondary analysisSymptomsProblematic symptomsClinical settingDepressed moodCohort
2008
Premenstrual syndrome
Yonkers KA, O'Brien P, Eriksson E. Premenstrual syndrome. The Lancet 2008, 371: 1200-1210. PMID: 18395582, PMCID: PMC3118460, DOI: 10.1016/s0140-6736(08)60527-9.Peer-Reviewed Original ResearchConceptsSevere premenstrual syndromePremenstrual dysphoric disorderPremenstrual syndromeSerotonin reuptake inhibitorsGonadal hormone levelsGonadotropin-releasing hormoneOral contraceptivesReuptake inhibitorsBreast tendernessSerotonergic synapsesReproductive ageHormone levelsDysphoric disorderLuteal phaseOvary axisMost womenOvarian cyclicityBehavioral symptomsDepressed moodSymptomsMood swingsSomatic complaintsPhysical discomfortWomenDaily activities
2005
Efficacy of a New Low-Dose Oral Contraceptive With Drospirenone in Premenstrual Dysphoric Disorder
Yonkers KA, Brown C, Pearlstein TB, Foegh M, Sampson-Landers C, Rapkin A. Efficacy of a New Low-Dose Oral Contraceptive With Drospirenone in Premenstrual Dysphoric Disorder. Obstetrics And Gynecology 2005, 106: 492-501. PMID: 16135578, DOI: 10.1097/01.aog.0000175834.77215.2e.Peer-Reviewed Original ResearchConceptsPremenstrual dysphoric disorderPlacebo groupSymptom scoresDysphoric disorderNew low dose oral contraceptiveLow-dose oral contraceptivesBehavioral symptom scoresActive treatment groupDaily symptom scoresPhysical symptom scoresEthinyl estradiol groupInactive pillsOral contraceptivesEstradiol groupClinical trialsEthinyl estradiolTreatment cyclesTotal Daily RecordI. EfficacyDrospirenoneSymptomsPill formulationDisordersOCP formulationsPlaceboPretreatment pattern of symptom expression in premenstrual dysphoric disorder
Pearlstein T, Yonkers KA, Fayyad R, Gillespie JA. Pretreatment pattern of symptom expression in premenstrual dysphoric disorder. Journal Of Affective Disorders 2005, 85: 275-282. PMID: 15780697, DOI: 10.1016/j.jad.2004.10.004.Peer-Reviewed Original ResearchConceptsPremenstrual dysphoric disorderPMDD symptomsMenstrual cycleDysphoric disorderPatient variabilityIntermittent dosing strategyOnset of menstruationDSM-IV criteriaPatients' durationAnxiety/tensionSertraline treatmentDRSP scoresPatient daysDosing strategiesSevere symptomsDay 2SymptomsTreatment studiesPretreatment patternAnger/irritabilityMood swingsMore daysWomenSymptom expressionTreatment implications